Volume 60, Issue 4, Pages (October 2011)

Slides:



Advertisements
Similar presentations
Volume 42, Issue 1, Pages 7-11 (July 2002)
Advertisements

The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
Medical Management for BPH: The Role of Combination Therapy
Dietary Antioxidants and Longitudinal Changes in Lower Urinary Tract Symptoms in Elderly Men: The Osteoporotic Fractures in Men Study  Kathleen F. Holton,
Volume 59, Issue 2, Pages (February 2011)
Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men
J.C. Trussell, M.D., Allen R. Kunselman, M.A., Richard S. Legro, M.D. 
Volume 72, Issue 1, Pages (January 2017)
Volume 68, Issue 3, Pages (September 2015)
Volume 191, Issue 3, Pages (March 2014)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 65, Issue 1, Pages (January 2014)
What Can Be Done to Maintain Men's Health: Perspectives from the EAU Young Academic Urologists Working Party Men's Health Group  Ege Can Serefoglu, Christian.
Volume 57, Issue 5, Pages (May 2010)
Volume 67, Issue 1, Pages (January 2015)
Management of Acute and Chronic Retention in Men
Volume 54, Issue 6, Pages (December 2008)
Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction  Steven A. Kaplan,
The Correlation Between Metabolic Syndrome and Prostatic Diseases
Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey  Varant Kupelian,
Volume 64, Issue 4, Pages (October 2013)
Volume 50, Issue 6, Pages (December 2006)
The Relationship between Erectile Dysfunction and Lower Urinary Tract Symptoms and the Role of Phosphodiesterase Type 5 Inhibitors  Tobias S. Köhler,
Volume 63, Issue 3, Pages (March 2013)
Prostate Cancer Epidemic in Sight?
Volume 64, Issue 4, Pages (October 2013)
Volume 59, Issue 2, Pages (February 2011)
Volume 55, Issue 2, Pages (February 2009)
Volume 63, Issue 1, Pages (January 2013)
Back to the Future: Introduction and Conclusions
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH)  Raymond C. Rosen, Francois Giuliano, Culley.
Volume 52, Issue 3, Pages (September 2007)
Pseudohyperplastic Adenocarcinoma of the Prostate
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Volume 71, Issue 3, Pages (March 2017)
Volume 60, Issue 1, Pages (July 2011)
Volume 60, Issue 4, Pages (October 2011)
Inflammation and Chronic Prostatic Diseases: Evidence for a Link?
Prostate Cancer Epidemic in Sight?
Volume 64, Issue 2, Pages (August 2013)
Volume 71, Issue 4, Pages (April 2017)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 44, Issue 5, Pages (November 2003)
Volume 70, Issue 6, Pages (December 2016)
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Richard C. Harkaway  European Urology Supplements 
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Volume 50, Issue 3, Pages (September 2006)
Volume 50, Issue 5, Pages (November 2006)
Volume 46, Issue 5, Pages (November 2004)
Volume 53, Issue 6, Pages (June 2008)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Tim Schneider  European Urology Supplements 
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Volume 54, Issue 6, Pages (December 2008)
Volume 53, Issue 6, Pages (June 2008)
European Urology is “Your” Journal
Emmanuel Chartier-Kastler, Kate Davidson  European Urology Supplements 
Martin Michel, Jean de la Rosette  European Urology Supplements 
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
The Benefits of Dual Inhibition of 5α Reductase
C.G Roehrborn, T McNicholas  European Urology Supplements 
Classification of Mixed Incontinence
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Michael Marberger  European Urology Supplements 
Presentation transcript:

Volume 60, Issue 4, Pages 809-825 (October 2011) Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia  Mauro Gacci, Ian Eardley, Francois Giuliano, Dimitris Hatzichristou, Steven A. Kaplan, Mario Maggi, Kevin T. McVary, Vincenzo Mirone, Hartmut Porst, Claus G. Roehrborn  European Urology  Volume 60, Issue 4, Pages 809-825 (October 2011) DOI: 10.1016/j.eururo.2011.06.037 Copyright © 2011 European Association of Urology Terms and Conditions

Figure 1 Schematic representation of the common pathogenetic mechanisms linking lower urinary tract symptoms resulting from benign prostatic hyperplasia and erectile dysfunction. NO=nitric oxide; cGMP=cyclic guanosine monophosphate; ROCK=Rho-kinase; BPH=benign prostatic hyperplasia; LUTS=lower urinary tract symptoms; ED=erectile dysfunction. European Urology 2011 60, 809-825DOI: (10.1016/j.eururo.2011.06.037) Copyright © 2011 European Association of Urology Terms and Conditions